PRCT Stock: Price, Earnings History and SEC Filings
PROCEPT BioRobotics Corporation (PRCT) last traded at $19.20, down 5.42% on the latest session and up 5.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.47 against an analyst estimate of $-0.46, a miss of 2.2%.
$19.20 -5.42%
1 month+5.38%
52-week high$38.11
52-week low$16.67
Volume856,458
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PRCT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $-0.47 | $-0.46 | -2.17% |
| Mar 2026 | Apr 29, 2026 | $-0.56 | $-0.55 | -1.82% |
| Dec 2025 | Feb 25, 2026 | $-0.53 | $-0.32 | -65.63% |
| Sep 2025 | Nov 4, 2025 | $-0.38 | $-0.41 | +7.32% |
PRCT beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
PRCT financial history
Revenue
Net income
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $308M | -$96M | -$58M | -31.0% | $-1.72 |
| 2024 | $224M | -$91M | -$104M | -40.7% | $-1.75 |
| 2023 | $136M | -$106M | -$133M | -77.8% | $-2.24 |
| 2022 | $75M | -$87M | -$83M | -116.2% | $-1.96 |
| 2021 | $34M | -$60M | -$58M | -173.6% | $-3.63 |
| 2020 | $8M | -$53M | -$49M | -687.0% | $-14.47 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for PRCT
SEC filing data is not available right now. You can search for PRCT on SEC EDGAR.
PRCT news
- PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Oct 28, 2026 · finance.yahoo.com
- PROCEPT BioRobotics (PRCT) Stock May Be Fully Priced On Cash Flow HopesOct 25, 2026 · finance.yahoo.com
- PROCEPT BioRobotics: Compelling Bet On Aquablation's GrowthOct 22, 2026 · seekingalpha.com
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation (PRCT) is a US-listed public company on Nasdaq.